🏥 Apollo Hospitals Enterprise Q3 Results: Profit Jumps 35%, Double-Digit Growth Across Businesses

Apollo Hospitals Enterprise Ltd delivered a strong Q3 performance, with net profit surging 35% YoY to ₹502 crore, driven by robust execution across hospitals, diagnostics, and omni-channel health-commerce businesses. The company also announced an interim dividend of ₹10 per share. Consolidated revenue rose 17% YoY to ₹6,477 crore, while EBITDA increased 27% to ₹965 crore, translating into a 112 bps margin expansion to 14.9%, despite absorbing ₹124 crore of Apollo 24/7 costs, including a ₹38 crore non-cash ESOP charge. For the 9M FY26 period, revenue grew 15% to ₹18,623 crore, while PAT jumped 34% to ₹1,412 crore, highlighting sustained operating leverage. 🔍 Segment-wise Performance Highlights Healthcare Services (Hospitals): • Revenue up 14% YoY to ₹3,183 crore • EBITDA rose 18% to ₹790 crore • Margins steady at 24.8% • Overall occupancy at 67% • Strong regional growth across Tamil Nadu, AP/Telangana, Karnataka, East, West, and North India Apollo Health & Lifestyle (AHLL): • Revenue grew 20% to ₹467 crore • EBITDA jumped 39% YoY • Losses narrowed, with PAT improving to –₹6 crore from –₹8 crore Apollo HealthCo (Digital + Omni-Channel Pharmacy): • Revenue rose 20% to ₹2,827 crore • EBITDA more than doubled to ₹128 crore from ₹57 crore • PAT increased sharply to ₹87 crore from ₹32 crore • 185 new stores added, taking total outlets to 7,113 • Private-label penetration at 15.5% • Online transactions up 31% YTD, strengthening omni-channel traction 📌 StockYard View Apollo Hospitals continues to compound profitably across core hospitals and high-growth digital health platforms, with improving margins, expanding capacity, and strong omni-channel execution supporting a long-term structural growth story. #ApolloHospitals #HealthcareStocks #Q3Results #HospitalSector #EarningsGrowth #StockYardResearch